BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8127023)

  • 1. Atrial natriuretic peptide and cGMP inhibit Na+/H+ antiporter in vascular smooth muscle cells in culture.
    Caramelo C; López-Farré A; Riesco A; Olivera A; Okada K; Cragoe EJ; Tsai P; Briner VA; Schrier RW
    Kidney Int; 1994 Jan; 45(1):66-75. PubMed ID: 8127023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume-dependent regulation of sodium and potassium fluxes in cultured vascular smooth muscle cells: dependence on medium osmolality and regulation by signalling systems.
    Orlov SN; Resink TJ; Bernhardt J; Buhler FR
    J Membr Biol; 1992 Aug; 129(2):199-210. PubMed ID: 1331467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action.
    Touyz RM; Picard S; Schiffrin EL; Deschepper CF
    J Neurochem; 1997 Apr; 68(4):1451-61. PubMed ID: 9084415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor and cGMP inhibit amiloride-sensitive Na+ transport in the cultured renal epithelial cell line, LLC-PK1.
    Cantiello HF; Ausiello DA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):852-60. PubMed ID: 3004467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Na-K-Cl cotransport, Na,K-adenosine triphosphatase, and Na/H exchanger in human neuroblastoma NB-OK-1 cells by atrial natriuretic peptide.
    Delporte C; Winand J; Poloczek P; Christophe J
    Endocrinology; 1993 Jul; 133(1):77-82. PubMed ID: 8391430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclic GMP in atrial natriuretic factor stimulation of Na+,K+,Cl- cotransport in vascular smooth muscle cells.
    O'Donnell ME; Owen NE
    J Biol Chem; 1986 Nov; 261(33):15461-6. PubMed ID: 2430959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active atrial natriuretic peptides selectively activate Na/K/Cl cotransport in vascular smooth muscle cells.
    O'Donnell ME; Bush EN; Holleman W; Owen NE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):822-8. PubMed ID: 2826759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
    Schiffrin EL; Turgeon A; Tremblay J; Deslongchamps M
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H58-65. PubMed ID: 1847018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
    Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
    Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
    Kumar R; Cartledge WA; Lincoln TM; Pandey KN
    Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide inhibits amiloride-sensitive sodium uptake in rat brain.
    Kanda F; Sarnacki P; Arieff AI
    Am J Physiol; 1992 Aug; 263(2 Pt 2):R279-83. PubMed ID: 1324615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of cation transport of vascular smooth muscle cells in a high glucose concentration milieu.
    Kuriyama S; Tokudome G; Tomonari H; Utsunomiya Y; Matsui K; Hashimoto T; Sakai O
    Diabetes Res Clin Pract; 1994 Jun; 24(2):77-84. PubMed ID: 7956712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells.
    Khurana ML; Pandey KN
    Mol Cell Biochem; 1996 May; 158(2):97-105. PubMed ID: 8817470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
    Bellemann P; Neuser D
    J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic GMP in atrial-natriuretic-peptide stimulation of erythrocyte Na+/H+ exchange.
    Petrov V; Amery A; Lijnen P
    Eur J Biochem; 1994 Apr; 221(1):195-9. PubMed ID: 7909516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Na-K-Cl cotransport in cultured vascular endothelial cells by atrial natriuretic peptide.
    Fujita T; Hagiwara H; Ohuchi S; Kozuka M; Ishido M; Hirose S
    Biochem Biophys Res Commun; 1989 Mar; 159(2):734-40. PubMed ID: 2539125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atrial natriuretic factor on Na+-K+-Cl- cotransport of vascular smooth muscle cells.
    Owen NE; Bush EN; Holleman W; O'Donnell ME
    Hypertension; 1987 Nov; 10(5 Pt 2):I128-30. PubMed ID: 2824361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 8-bromo-cyclic guanosine monophosphate on intracellular pH and calcium in vascular smooth muscle.
    Lockette W; McCurdy R; Aronow H; Butler B
    Hypertension; 1989 Jun; 13(6 Pt 2):865-9. PubMed ID: 2544526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
    Zhang LM; Tao H; Newman WH
    Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
    Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
    Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.